Abstract: An inhalation-activated inhalator having a primary inhalation passage and a secondary inhalation passage disposed in communication with the primary inhalation passage and a source of medicament. The primary inhalation passage has airflow inhibiting mechanism connected to a blocking plate positioned to selectively block fluid flow in the secondary inhalation passage. As the user's inhalation reaches a defined rate, the flow inhibiting mechanism restricts flow through the primary inhalation passage and moves the blocking plate to enable airflow through the secondary passage. Thus, as the user achieves a desired inhalation rate, the medicament is provided through the secondary inhalation passage, thereby optimizing the delivery of medicament to the lungs.
Type:
Grant
Filed:
November 27, 2001
Date of Patent:
May 13, 2003
Assignee:
Innovative Devices
Inventors:
Robert A. Casper, Frank A. Leith, David L. Gardner, John M. Snow, Zachary W. Lyon, David S. Farrar
Abstract: An inhalation-activated inhalator having a primary inhalation passage and a secondary inhalation passage disposed in communication with the primary inhalation passage and a source of medicament. The primary inhalation passage has a flow inhibiting mechanism connected to a blocking plate positioned to selectively block fluid flow between the secondary and primary inhalation passage. As the user's inhalation reaches a defined rate, the flow inhibiting mechanism restricts flow through the primary inhalation passage and moves the blocking plate to enable airflow through the secondary passage. Thus, as the user achieves a desired inhalation rate, the medicament is provided through the secondary inhalation passage, thereby optimizing the delivery of medicament to the lungs.
Type:
Grant
Filed:
May 11, 1998
Date of Patent:
November 23, 1999
Assignee:
Innovative Devices
Inventors:
Robert A. Casper, Frank A. Leith, David L. Gardner
Abstract: An inhalation-activated inhalator having a primary inhalation passage and a secondary inhalation passage disposed in communication with the primary inhalation passage and a source of medicament. The primary inhalation passage has a flow inhibiting mechanism connected to a blocking plate positioned to selectively block fluid flow between the secondary and primary inhalation passage. As the user's inhalation reaches a defined rate, the flow inhibiting mechanism restricts flow through the primary inhalation passage and moves the blocking plate to enable airflow through the secondary passage. Thus, as the user achieves a desired inhalation rate, the medicament is provided through the secondary inhalation passage, thereby optimizing the delivery of medicament to the lungs.
Type:
Grant
Filed:
March 25, 1997
Date of Patent:
October 20, 1998
Assignee:
Innovative Devices
Inventors:
Robert A. Casper, Frank A. Leith, David L. Gardner